• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Fc microparticles can modulate the physical extent and magnitude of complement activity?
  David White,Sean R. Stowell Biomater. Sci., 2017,5, 463-474
• 3. Evolved polymerases facilitate selection of fully 2′-OMe-modified aptamers?
  Zhixia Liu,Tingjian Chen,Floyd E. Romesberg Chem. Sci., 2017,8, 8179-8182
• 4. Excellent peroxidase mimicking property of CuO/Pt nanocomposites and their application as an ascorbic acid sensor?
  Xinhuan Wang,Shuangfei Cai,Cui Qi Analyst, 2017,142, 2500-2506
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Phenylpropylamines

Comprehensive Guide to 3-(3-bromophenyl)propan-1-amine hydrochloride (CAS No. 1269151-20-3): Properties, Applications, and Market Insights

3-(3-bromophenyl)propan-1-amine hydrochloride (CAS No. 1269151-20-3) is a specialized organic compound that has gained significant attention in pharmaceutical and chemical research. This brominated aromatic amine derivative serves as a crucial intermediate in the synthesis of various bioactive molecules. With the increasing demand for pharmaceutical intermediates in drug discovery, compounds like 3-(3-bromophenyl)propan-1-amine HCl have become essential building blocks for medicinal chemists.

The molecular structure of 3-(3-bromophenyl)propan-1-amine hydrochloride features a bromophenyl group attached to a three-carbon aliphatic chain terminating in an amine functionality. This unique combination of aromatic and aliphatic characteristics makes it particularly valuable for creating drug-like molecules with optimal pharmacokinetic properties. Recent trends in AI-assisted drug discovery have highlighted the importance of such versatile chemical building blocks in accelerating the development of new therapeutic agents.

In pharmaceutical applications, 3-(3-bromophenyl)propan-1-amine HCl serves as a precursor for numerous CNS-active compounds. The bromine substituent at the meta position offers excellent opportunities for further functionalization through modern cross-coupling reactions, making this compound particularly valuable in medicinal chemistry workflows. Researchers are increasingly interested in how such halogenated intermediates can contribute to the development of next-generation therapeutics targeting neurological disorders.

The synthesis and handling of 3-(3-bromophenyl)propan-1-amine hydrochloride require specialized knowledge of organic synthesis techniques. Proper storage conditions typically involve protection from moisture and light to maintain the compound's stability. As with many pharmaceutical intermediates, quality control parameters such as purity, residual solvents, and heavy metal content are critical considerations for end-users in the pharmaceutical industry.

Market analysis indicates growing demand for 3-(3-bromophenyl)propan-1-amine HCl across multiple regions, particularly in pharmaceutical research hubs. The compound's versatility in drug discovery applications has made it a sought-after material among contract research organizations and academic laboratories. Current research trends suggest expanding applications in developing targeted therapies and precision medicine approaches.

From a regulatory perspective, 3-(3-bromophenyl)propan-1-amine hydrochloride requires appropriate handling according to standard laboratory safety protocols. While not classified as hazardous under normal conditions, researchers should consult the latest safety data sheets for specific handling instructions. The compound's increasing popularity in high-throughput screening platforms underscores its importance in modern drug discovery pipelines.

Recent advances in green chemistry have prompted investigations into more sustainable synthetic routes for producing 3-(3-bromophenyl)propan-1-amine HCl. These efforts align with the pharmaceutical industry's broader goals of reducing environmental impact while maintaining chemical synthesis efficiency. The compound's role in developing biodegradable pharmaceuticals represents an exciting area of current research.

Analytical characterization of 3-(3-bromophenyl)propan-1-amine hydrochloride typically involves techniques such as HPLC analysis, mass spectrometry, and NMR spectroscopy. These methods ensure the compound meets the stringent purity requirements for pharmaceutical applications. The growing adoption of quality-by-design principles in chemical manufacturing has further elevated the importance of robust analytical methods for intermediates like 3-(3-bromophenyl)propan-1-amine.

The future outlook for 3-(3-bromophenyl)propan-1-amine hydrochloride appears promising, with potential applications emerging in personalized medicine and combinatorial chemistry. As drug discovery paradigms evolve to emphasize structure-activity relationships, the demand for well-characterized chemical building blocks like this compound is expected to grow. Ongoing research into its structure-property relationships may unlock additional applications in material science and specialty chemicals.

For researchers considering 3-(3-bromophenyl)propan-1-amine HCl for their projects, it's essential to evaluate the compound's compatibility with intended chemical transformations. The bromine atom offers excellent opportunities for palladium-catalyzed couplings, while the primary amine functionality provides numerous derivatization possibilities. These features make it particularly valuable in lead optimization stages of drug development programs.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)